NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets
NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets
Recalling Firm: Drugs and health products
Motif du rappel / Danger
TranslatedProduct safety
Description du produit & Identification
TranslatedCheck your medication bottle to ensure it only contains NRA-AMLODIPINE 5 mg tablets.If your bottle contains any round tablets, which are not the correct shape, or if you're unsure, return the bottle to your pharmacy for a replacement.If you are unable to get a replacement immediately, continue to take your medication as directed, but do not take the round tablets as these are the wrong medication.Contact your health care professional if you are dizzy, have unusually low blood pressure or slow heartbeats. If you are unable to access a health care professional and you are experiencing these symptoms, call 911.If you have questions about this recall, contact Nora Pharma Inc. by calling their Quality Assurance Department at 450-904-2355 or by emailing info@norapharma.ca.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals:Health care professionals, such as pharmacists, should check packages and bottles labelled NRA-AMLODIPINE 5 mg (amlodipine besylate) before dispensing to make sure they do not contain Metoprolol Succinate prolonged-release 12.5 mg tablets. Report any unusual bottles or other issues to the company and Health Canada.
Produits concernés
TranslatedNRA-AMLODIPINE 5MG
Additional Source Details
| Field | Value |
|---|---|
| N I D | 77705 |
| U R L | https://recalls-rappels.canada.ca/en/alert-recall/nra-amlodipine-5mg-affected-lot-may-contain-tablets-metoprolol-succinate-prolonged |
| Issue | Product safety |
| Title | NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets |
| Product | NRA-AMLODIPINE 5MG |
| Archived | 0 |
| Category | Drugs |
| Last updated | 2025-07-08 |
| Organization | Drugs and health products |
| Recall class | Type I |
| What you should do | Check your medication bottle to ensure it only contains NRA-AMLODIPINE 5 mg tablets.If your bottle contains any round tablets, which are not the correct shape, or if you're unsure, return the bottle to your pharmacy for a replacement.If you are unable to get a replacement immediately, continue to take your medication as directed, but do not take the round tablets as these are the wrong medication.Contact your health care professional if you are dizzy, have unusually low blood pressure or slow heartbeats. If you are unable to access a health care professional and you are experiencing these symptoms, call 911.If you have questions about this recall, contact Nora Pharma Inc. by calling their Quality Assurance Department at 450-904-2355 or by emailing info@norapharma.ca.Report any health product-related side effects or complaints to Health Canada.Additional information for health professionals:Health care professionals, such as pharmacists, should check packages and bottles labelled NRA-AMLODIPINE 5 mg (amlodipine besylate) before dispensing to make sure they do not contain Metoprolol Succinate prolonged-release 12.5 mg tablets. Report any unusual bottles or other issues to the company and Health Canada. |
Consumer Action Protocol: What You Should Do Immediately
Safety StepsCheck the model number, serial number, and date stamp on the rating label on the back or underside of the product.
Immediately discontinue using the product. Unplug electrical items and keep juvenile items out of reach of children.
Under statutory consumer protection rules, consumers are entitled to a full refund, certified replacement, or free repair kit without needing the original sales receipt.
If you suffered an injury, illness, or property damage from this product, file an official incident report with regulatory authorities (Health Canada).
Your Legal Rights as a Consumer
Recalls are legally binding corrective safety actions overseen by statutory government bodies. Recalling entities are legally prohibited from charging consumers for official safety remedies. If a retailer or dealership refuses your recall remedy, notify the issuing regulatory agency immediately.
Frequently Asked Questions About This Recall
FAQ GuideQ1:What should I do immediately if I own or bought NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets?
Immediately stop using the product and keep it out of reach of children. Disconnect power if electrical, and do not attempt makeshift home repairs.
Q2:Can I get a full refund or free repair for this recall?
Yes. Recalling manufacturers and retail merchants are required under consumer protection regulations to offer a statutory remedy—typically a full refund, certified repair kit, or replacement unit.
Q3:Do I need my original sales receipt to claim a remedy or refund?
In most recall cases, no receipt is required. Because safety recalls are matters of public health and statutory compliance, retailers and manufacturers routinely issue refunds, store credit, or replacement kits upon presentation of the affected product or lot code.
Q4:Where can I verify official information for this safety alert?
This safety alert is aggregated directly from official regulatory agency records (Health Canada). You can click the 'Official Agency Alert' link on this page to view the primary government notice and contact the manufacturer directly.
Vérifiez les autres produits de votre foyer
Outils gratuitsSafety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:
Aperçu
- Entreprise responsableDrugs and health products
- Niveau de risqueType I
📢 Partager l’alerte
Alert family and friends to keep them safe. Copy this quick alert message:
🚨 SAFETY ALERT: Drugs and health products - NRA-AMLODIPINE 5MG: Affected lot may contain tablet(s) of Metoprolol Succinate prolonged–release 12.5 mg tablets Check if your household is affected: https://therecallfile.com/fr/recalls/nra-amlodipine-5mg-affected-lot-may-contain-tablet-s-of-metoprolol-suc/CANADA-77705
Rejoindre la liste d’alerte
Recevez des alertes e-mail instantanées dès qu’un rappel critique est publié.
Support The Recall File
Help keep official recall alerts free, accessible, and fast for everyone.